Jpm 2025 Biotech Showcase 2025. Register for Expo 2025 Home / Resources / Conferences / JP Morgan Healthcare Conference and Biotech Showcase 2025 JP Morgan Healthcare Conference and Biotech Showcase 2025 Biotech Showcase 2025, the investor and partnering conference for private, small- and mid-cap biotech companies, took place 13-15 January 2025 in San Francisco, CA, US
JPM 2025 Annual Healthcare Conference 2025 from 2025.jpmhealthcareconference.org
Biotech Showcase™, the investor conference in San Francisco produced by Demy-Colton and EBD Group, is devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to investors and pharmaceutical executives. Registration Access to Partnering Platform Now Open.
JPM 2025 Annual Healthcare Conference 2025
The event has been organised by EBD Group & Demy-Colton. Our experts will be on the ground in San Francisco during the JP Morgan Healthcare Conference, and Biotech Showcase: The Investor Conference for Innovators to discuss your specific asset challenges and how we can drive success across the asset development continuum, providing fit-for-purpose solutions with high-quality delivery. Save the date for next year January 12-14, 2026 | San Francisco, CA
JP 2025 BIOVECTRA. Biotech Showcase™ 2025: 3,200+ Attendees and 1,200+ Investors Set to Convene in San Francisco for Leading Biotech Investor Conference 13 January 2025 15 January 2025 California, USA Hilton San Francisco Union Square A premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering a unique opportunity to showcase innovations and engage one-to-one with investors and executives.
JPM Biotech Showcase Presentation — Reglagene Transforming Tubulin Therapy for Brain Diseases. Save the date for next year January 12-14, 2026 | San Francisco, CA Our experts will be on the ground in San Francisco during the JP Morgan Healthcare Conference, and Biotech Showcase: The Investor Conference for Innovators to discuss your specific asset challenges and how we can drive success across the asset development continuum, providing fit-for-purpose solutions with high-quality delivery.